InProTher
InProTher is creating advanced cancer immunotherapies based on pre-clinical models with Professor Holst.
2-10 employees · est. 2018
iOmx Therapeutics AG
Developing next-generation targeted cancer immunotherapy treatments
53 employees · est. 2016 · Germany
iOmx Therapeutics AG is the older company (2018 vs 2016); iOmx Therapeutics AG is the larger of the two.
Side-by-Side Comparison
| Metric | InProTher | iOmx Therapeutics AG |
|---|---|---|
| Founded | ||
| Founded | 2018 | 2016 older |
| Headquarters | ||
| Headquarters | Not tracked yet | Germany |
| Employees | ||
| Employees | 2-10 | 53 larger |
| Industry | ||
| Industry | Biotechnology, Health Care | Biopharma, Health Care, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Seed | Series B |
| Total Funding | ||
| Total Funding | $8.50M | $105.00M |
| Funding Rounds | ||
| Funding Rounds | 3 | 2 |
| Services | ||
| Services | Not tracked yet | Development of targeted cancer immunotherapy treatments, Translating immune evasion biology into drug programs, Innovative drug pipeline, Novel immune checkpoint target identification |
| Target Customers | ||
| Target Customers | Not tracked yet | Cancer patients, Healthcare providers, Oncologists, Pharmaceutical companies, Biotech investors |
| Taxonomy | ||
| Taxonomy | Cancer Immunotherapy, Pre-clinical Models, Advanced Therapies, Immune Checkpoint Inhibitors, Tumor Immunity, Research Collaboration, Cancer Therapy Development, Immunotherapy Success, Professor Holst, Associate Professor Holst, Cancer Research, Cancer Treatment Innovations | Immuno-oncology, Targeted Cancer Therapy, Immune Checkpoint Modulators, Drug Development, Pre-clinical Development, Clinical Development, Tumor Immunology, Checkpoint Inhibitors, Tumor Cell Screening, Immune Resistance Mechanisms, Novel Target Identification, Immune Response Reactivation, Biotechnology Start-up, Therapeutic Portfolio |
| Website | ||
| Website | inprother.com | iomx.com |
About InProTher
InProTher is a biotechnology startup founded in 2018, dedicated to creating cutting-edge cancer immunotherapies. The company's slogan, "InProTher is creating advanced cancer immunotherapies based on pre-clinical models with Professor Holst," succinctly captures its mission. With a focus on pioneerin...
About iOmx Therapeutics AG
iOmx Therapeutics AG is positioned at the forefront of the immuno-oncology sector, striving to revolutionize cancer treatment with its next-generation targeted cancer immunotherapy solutions. Founded in 2016 and headquartered in Germany, iOmx utilizes its robust technology platform to advance a port...
We will tell you when either one moves
BounceWatch watches InProTher and iOmx Therapeutics AG for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at InProTher and iOmx Therapeutics AG — by email.
Frequently Asked Questions
Compare InProTher with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at InProTher on 11 Sep 2024, and iOmx Therapeutics AG on 28 May 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.